3s Pharmacological Consultation & Res. S.R.L.
- Address
- lock Available on a paid plan
Infectious Disease Research
The Clinical Research Department at 3s Pharmacological Consultation & Res. S.R.L. in Cumparatura, Romania, is engaged in clinical research focused on infectious diseases. This pharmaceutical research organization conducts studies aimed at evaluating therapeutic interventions for viral infections and related conditions. The facility's work contributes to the broader understanding of treatment options for patients affected by infectious pathogens.
- Evaluation of antiviral therapies
- Assessment of treatment efficacy in viral infections
- Investigation of novel therapeutic approaches
The site's research portfolio reflects a commitment to advancing medical knowledge in the field of infectious disease management, with particular emphasis on developing and testing interventions that may improve patient outcomes in viral illness management.
Pharmaceutical Clinical Research Operations
As a commercial pharmaceutical research organization located in Romania, the facility operates within the European clinical trial network. The research conducted here involves systematic evaluation of pharmacological interventions under controlled conditions. Studies are designed to assess the safety and effectiveness of potential treatments across various patient populations.
- Clinical trial management and execution
- Patient recruitment and monitoring
- Data collection and analysis for therapeutic evaluation
The site's infrastructure supports comprehensive clinical investigation, enabling the collection of valuable data that contributes to regulatory submissions and evidence-based medicine. Through its focused research activities, the organization plays a role in the development pipeline for new pharmaceutical products.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Ratiopharm GmbH1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in 3s Pharmacological Consultation & Res. S.R.L.
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Bioequivalence Study of Furosemide 500 mg Tablets Versus Lasix 500 mg Tablets in Healthy Male Volunteers Under Fasting Conditions | Ratiopharm GmbH | Phase I | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2023-10-24 | 2023-10-24 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.